Alabama · 2026 Regular Session · Bill
HB 533: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 533 is a bill introduced in the Alabama House on March 3, 2026. According to its official title, it concerns: Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded. Primary sponsor: Margie Wilcox (Republican). Most recent recorded action (April 17, 2026): Enacted.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Health
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Margie Wilcox | Primary sponsor | Republican | House | 104 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Enacted
- Ready to Enroll
- Enrolled
- Signature Requested
- Delivered to Governor
- Motion to Read a Third Time and Pass - Adopted Roll Call 1271
- Reported Out of Committee Second House
- Read for the Second Time and placed on the Calendar (Healthcare)
- Read for the first time and referred to the Senate Committee on Healthcare
- Pending Committee Action in Second House (Healthcare)
- Third Reading in House of Origin
- Motion to Read a Third Time and Pass - Adopted Roll Call 966
Showing 12 most recent of 16 actions. Full history